Skip to main content

Table 2 Treatment effects of Nigella sativa and placebo on fasting blood glucose (FBG) and blood pressure levels

From: A randomised controlled trial on hypolipidemic effects of Nigella Sativa seeds powder in menopausal women

Parameters

Baseline

1stmonth

2ndmonth

Follow up

 

N. sativa

Placebo

N. sativa

Placebo

N. sativa

Placebo

N. sativa

Placebo

FBG (mmol/L)

6.37 ± 0.61*

5.94 ± 0.44

5.69 ± 0.43*

5.81 ± 0.31

5.03 ± 0.51*

5.73 ± 0.75

5.48 ± 0.42*

5.70 ± 0.66

SBP (mmHg)

129.33 ± 15.44

138.40 ± 18.90

121.80 ± 17.40

131.27 ± 19.22

124.53 ± 13.31

140.71 ± 11.85

125.84 ± 15.48

144.71 ± 19.84

DBP (mmHg)

77.13 ± 9.16

83.93 ± 15.73

76.00 ± 12.90

79.53 ± 13.83

75.53 ± 9.56

89.00 ± 12.53

75.98 ± 10.64

93.00 ± 15.16

  1. Values are mean ± SD. There was a downward trend in the means of the groups for both N. sativa and placebo over 2 months of intervention but no significant differences were observed.
  2. *Significant between N. S vs. placebo group at p < 0.05. SBP: systolic blood pressure; DBP: diastolic blood pressure.